Tag:
atacicept
Latest Headlines
Latest Headlines
Investigators suspend trial of ZymoGenetics' drug
There's more bad news for ZymoGenetics' experimental drug atacicept this morning. The developer ( ZGEN ) announced that Merck Serono has decided to suspend clinical trials of the drug as a treatment
